Valeant Pharmaceuticals Chief Returns From Medical Leave

February 29, 2016 2:07 AM

10 0

Valeant Pharmaceuticals Chief Returns From Medical Leave

J. Michael Pearson has returned as the chief executive of Valeant Pharmaceuticals International after two months of medical leave, setting him up for the challenge of restoring investor confidence in the embattled company.

Valeant announced Sunday evening that Mr. Pearson had returned, effective immediately. Howard B. Schiller, who had been the interim chief executive in Mr. Pearson’s absence, will step down as a company executive but remain a member of the board.

Also read: Greek cenbank chief expects return to capital markets in mid-2018

Read more

To category page

Loading...